People
Peter Brown
The causes of Parkinson's disease. Specifically how abnormal synchronous activity in the brain causes slowness and stiffness in Parkinson's disease.
Daniel Bulte
Creating new neuroimaging techniques through the development of mathematical models of cerebral physiology from magnetic resonance imaging data.
M. Zameel Cader
The group’s research covers neurogenetic disorders, often rare variant of common disease. Understanding the disease pathways in these conditions will allow development of meaningful therapies. The group is developing new disease models for more effective drug discovery platforms.
Steven A Chance
Our projects study cognitive/psychiatric disorders and comparative evolutionary neuroscience. We are interested in the relationship between brain structure and function - particularly language and social cognition
Matt J Craner
One of the key research aims include the identification of molecular mechanisms that contribute to loss of neurons and axons in multiple sclerosis (MS) and targeting these mechanisms with neuroprotective drugs that can be rapidly translated to clinical practice.
Gabriele C. De Luca
Genetic-Pathologic Correlations in multiple sclerosis. Neuropathology of degenerative diseases.
Margaret Esiri
Clinical neuropathology with an interest particularly in dementia and multiple sclerosis
Alexander Green
Central Nervous System control of the Autonomic Nervous System, Pain and Deep Brain Stimulation.
David Hilton-Jones
Clinical aspects of inherited and acquired myopathies. Identification of genes associated with neuromuscular disorders
Michele T Hu
Role of clinical cohorts in the development of biomarkers in Parkinson’s disease (PD)
MRI and other brain imaging techniques in early and premotor PD
Christopher Kennard
My research interests include cortical disorders of vision and cognitive neuroscience particularly using eye movements to understand brain function and as biomarkers for neurodegenerative diseases.
Bethan Lang
Autoimmune Diseases of the peripheral and central nervous system. Autoimmune epilepsy; Rasmussen’s encephalitis; Opsoclonus myoclonus syndrome; Lambert-Eaton myasthenic syndrome.
Peter M Rothwell
Stroke prevention, hypertension, effects of aspirin on risk of vascular and non-vascular disease, personalized medicine and randomized trials.
Ursula Schulz
MR-Imaging after TIA and minor stroke: clinical usefulness and new applications - Prognosis and risk factors in posterior circulation disease
Kevin Talbot
Our research aims to take the rapid advances occurring in the basic science of neurodegenerative diseases to develop new treatments to benefit patients, focussing on amyotrophic lateral sclerosis (motor neuron disease), spinal muscular atrophy and Parkinson’s disease.
Martin Turner
Dr Martin Turner is a Consultant Neurologist and Clinician Scientist. His research focus is the neurodegenerative disorder Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS) in its commonest form.
Patrick Waters
Antigen discovery in antibody mediated diseases of the central nervous system; development of diagnostic assays; development of models to help understand the pathogenic mechanism in these diseases; the use of modified innate immune molecules as therapeutics.
